Until

Until is building the medical infrastructure to pause biological time: starting with organ-scale reversible cryopreservation, and methodically scaling to whole-body preservation.

Until is active in the biotechnology & health space.

Within the biotechnology & health space, the company focuses on its core offering rather than a broad product line.

Its current recorded stage is Founders Fund portfolio company.

Website: www.untillabs.com